FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

Auteurs

Bas W.G. van Rhijn, Laura S. Mertens, Roman Mayr, Peter J. Bostrom, Francisco X. Real, Ellen C. Zwarthoff, Joost L. Boormans, Cheno Abas, Geert J.L.H. van Leenders, Stefanie Götz, Katrin Hippe, Simone Bertz, Yann Neuzillet, Joyce Sanders, Annegien Broeks, Michiel S. van der Heijden, Michael A.S. Jewett, Mirari Marquez, Robert Stoehr, Alexandre R. Zlotta, Markus Eckstein, Yanish Soorojebally, Hossain Roshani, Maximilian Burger, Wolfgang Otto, François Radvanyi, Nanor Sirab, Damien Pouessel, Bernd Wullich, Theo H. van der Kwast, Núria Malats, Arndt Hartmann, Yves Allory, Tahlita C.M. Zuiverloon